Perrigo - Best Pharma Stocks of 2007

Company: Perrigo
Starting stock price: $17.61
Ending stock price: $35.01
Percent Change: 98.81%

Details: Perrigo develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. In December 2007 Perrigo won FDA approval for an OTC, generic heartburn treatment the company will market in partnership with Dexcel Pharma.

More News:
Perrigo gets OK for generic heartburn drug. Report
Dexcel gets right to sell copycat Prilosec. Report

Perrigo - Best Pharma Stocks of 2007
Read more on

Suggested Articles

FDA officials say Novartis took too long to launch a formal probe into allegations of Zolgensma data manipulation.

Should Johnson & Johnson owe billions to fix Oklahoma's opioid crisis? After weeks of trial testimony, a judge will have his say Monday afternoon.

After Endo and Allergan agreed to settle with two Ohio counties on opioid charges this week, the state’s AG has a message: You’re not off the hook.